Detalhe da pesquisa
1.
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Acta Oncol
; 63: 385-391, 2024 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779910
2.
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia.
BMC Cancer
; 20(1): 201, 2020 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32164576
3.
Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.
BMC Cancer
; 18(1): 1075, 2018 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30404606
4.
Time Trends in Ovarian Cancer Survival in Estonia by Age and Stage.
Int J Gynecol Cancer
; 27(1): 44-49, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27870707
5.
A randomised, double-blind, dose-finding, phase II multicentre study of ODX in the treatment of patients with castration-resistant prostate cancer and skeletal metastases.
Eur J Cancer
; 181: 198-207, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36682096
6.
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study.
J Clin Oncol
; 38(5): 395-405, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31774688
7.
Increasing incidence and survival of corpus uteri cancer in Estonia over the past two decades.
Cancer Epidemiol
; 62: 101566, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31326850